Abstract:BACKGROUND Aldosterone has been implicated in a variety of organ fibroses, but its role and mechanism in liver fibrosis remain unclear. METHODS Rat primary hepatic stellate cells (HSCs) were isolated, cultured, and characterized. HSCs were incubated with aldosterone (10(-6) M) for 4 h, 8 h, 12 h, 24 h, and 48 h, after which TGF-β1 (transforming growth factor beta 1) expression was measured by real-time PCR. Rat HSCs were treated with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M), and the expressions of PAI-1 (plasminogen activator inhibitor-1) and TGF-β1 were determined by measuring mRNA and protein. HSCs were incubated in groups containing aldosterone (10(-6) M), spironolactone (10(-5) M), both aldosterone and spironolactone, or neither aldosterone nor spironolactone (control), after which mRNA and protein expression of PAI-1 and TGF-β1 were measured. Collagen I expression was detected by immunohistochemical analysis of supernatants of the aldosterone (10(-6) M), TGF-β1, and aldosterone plus TGF-β1 groups. SMAD expression was detected in rat HSC control, HSC plus aldosterone (10(-6) M), HSC plus TGF-β1, and HSC plus aldosterone plus TGF-β1 groups. RESULTS HSCs were incubated with aldosterone for 4 h, 8 h, 12 h, 24 h, and 48 h after which TGF-β1 expression was measured. We found that TGF-β1 expression increased in a time dependent manner and reached a peak at 24 h. The expression of TGF-β1 in groups treated with aldosterone for 4 h, 8 h, 12 h, and 24 h was significantly different from the control group (P < 0.01). No significant difference was seen in TGF-β1 expression between the groups treated with aldosterone for 24 h and 48 h (P > 0.05). Compared with the control group, TGF-β1 expression was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). There were significant differences in the expression of TGF-β1 between 10(-6) M and 10(-7) M aldosterone treatment groups (P < 0.01). Compared with the control group, the expression of PAI-1 was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). PAI-1 expression was increased in the aldosterone, spironolactone, and aldosterone plus spironolactone groups. The expression of PAI-1 was significantly enhanced in the aldosterone and aldosterone plus spironolactone groups compared with the control group (P < 0.01). There was a marked enhancement of collagen I expression in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). Collagen I expressions in the aldosterone and TGF-β1 groups were significantly different from the aldosterone plus TGF-β1 group (P < 0.01). Compared with the control group, SMAD expression was markedly elevated in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). The expression of SMAD was significantly increased in the aldosterone plus TGF-β1 group compared with the aldosterone group (P < 0.01). CONCLUSION This study demonstrated that aldosterone promoted HSC activation and the expression of TGF-β1, PAI-1, and collagen in hepatic fibrosis progression and that spironolactone administration partially reversed the effects. The aldosterone promotional effect on hepatic fibrosis was partially mediated by TGF-β1.

Effect of Atorvastatin on Myocardial Fibrosis Induced by Aldosterone

Effect of Atorvastatin on Aldosterone Induced Myocardial Fibrosis in A Rat Model and Its Potential Mechanism

Effects of Atorvastatin on Myocardium Expression of Peroxisome Proliferator-Activated Receptors in Spontaneously Hypertensive Rats

[Effects of Atorvastatin on Endothelium Protection in Spontaneously Hypertensive Rats].

Atorvastatin Improves Cardiac Lipid Metabolism in Spontaneous Hypertensive Rats and Ameliorates Cardiac Hypertrophy

Effects of Atorvastatin on Vascular Remodeling in Spontaneously Hypertensive Rats

Effect of Atorvastatin on Blood Pressure in Spontaneously Hypertensive Rats

Influence of atorvastatin on ion pump activity of smooth muscle cells and intima proliferation after arterial intimal injury

The Effects of Atorvastatin on Left Ventricular Remodeling in Spontaneously Hypertensive Rats

Effect of Atorvastatin on Non-Ischemic Heart Failure and Matrix Metalloproteinase-2 and 9 in Rats

Effects of Atorvastatin on Calcium-Regulating Proteins: a Possible Mechanism to Repair Cardiac Dysfunction in Spontaneously Hypertensive Rats

Effect of aliskiren on myocardial fibrosis induced by desoxycorticosterone acetate-salt

Effect of Aldosterone and Its Antagonist on the Expression of PAI-1 and TGF-β1 in Rat Hepatic Stellate Cells.

Effect of Atorvastatin on Ventricular Remodeling in Spontaneous Hypertension Rats

Experimental Investigation of the Effect of Aldosterone on Liver Fibrosis

Effect of Simvastatin on Regression of Pressure Overload-Induced Rat's Myocardial Fibrosis and Its Relationship with Monocyte Chemoattractant Protein-1

Spironolactone Improves Myocardial Fibrosis in Spontaneously Hypertensive Rats

Effect of Atorvastatin on Cardiac Function and TGF-β1 Signaling Pathway after Acute Myocardial Infarction in Rats

Anti-fibrotic effect of Aliskiren in rats with deoxycorticosterone induced myocardial fibrosis and its potential mechanism.

[Effects of Atorvastatin on the Proliferation and Collagen Synthesis of Rat Cardiac Fibroblasts].

The Protective Effect of Simvastatin on Myocardial Fibrosis of Rats with Diastolic Heart Failure